JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Lipid-Lowering Medication and Outcomes After Anatomical and Functional Imaging in Suspected Coronary Artery Disease

  • 0Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland; Department of Clinical Physiology, Nuclear Medicine and PET, Turku University Hospital, Turku, Finland.
Jacc. Cardiovascular Imaging +

|

August 29, 2024

|

August 29, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Lipid-lowering medication (LLM) use is guided by coronary artery disease (CAD) phenotypes identified through imaging. Patients with myocardial ischemia or obstructive CAD benefit long-term from LLM.

Area Of Science

  • Cardiology
  • Medical Imaging
  • Pharmacology

Background

  • Coronary artery disease (CAD) presents diverse phenotypes identifiable via anatomical and functional imaging.
  • These phenotypes may influence the effectiveness of lipid-lowering medication (LLM).

Purpose Of The Study

  • To investigate the association between LLM use and long-term patient outcomes.
  • To analyze these associations in the context of combined anatomical and functional imaging for suspected obstructive CAD.

Main Methods

  • 1,973 patients with suspected CAD underwent coronary computed tomography angiography (CTA).
  • Patients with non-ruled-out obstructive CAD received positron emission tomography ischemia testing.
  • LLM purchases were tracked for 2 years; adverse events (death, myocardial infarction, unstable angina) were assessed over a median of 6.7 years.

Main Results

  • LLM use varied by CAD phenotype: 24% (no CAD) to 91% (myocardial ischemia).
  • LLM use was linked to reduced adverse events in patients with myocardial ischemia and obstructive CAD without ischemia (P < 0.05).
  • No significant benefit was observed in patients with nonobstructive or no CAD.

Conclusions

  • CAD phenotype, determined by imaging, should guide LLM prescription.
  • Myocardial ischemia and obstructive coronary lesions indicate a long-term benefit from LLM therapy.

Keywords:

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents 01:20

596

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Imaging Studies for Cardiovascular System I:Echocardiography 01:17

303

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

Imaging Studies for Cardiovascular System III: X-Ray 01:20

160

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...